Concepedia

Ken Uchibori

KU

Statistics

Publications

27

Citations

1.1K

H-Index

17

Active since

2007

Affiliations

Japanese Foundation For Cancer Research(Current)

The Cancer Institute Hospital

Tokyo Medical and Dental University

Nippon Medical School

Kyoto University

Ken Uchibori is an author at Japanese Foundation For Cancer Research specializing in oncology, medicine, and molecular oncology.

Publications per year

2007–2024

27

Publications

27

Brigatinib combined with anti-EGFR antibody overcomes osimertinib resistance in EGFR-mutated non-small-cell lung cancer

Ken Uchibori, Naohiko Inase, Mitsugu Araki et al. · Nature Communications · 2017 · 410 citations · Full text

Medicine, Oncology, Pharmacology +14

High ratio of T790M to EGFR activating mutations correlate with the osimertinib response in non-small-cell lung cancer

Ryo Ariyasu, Shingo Nishikawa, Ken Uchibori et al. · Lung Cancer · 2018 · 53 citations

Medicine, Oncology, Pharmacology +17

Drug resistance mechanisms in Japanese anaplastic lymphoma kinase‐positive non–small cell lung cancer and the clinical responses based on the resistant mechanisms

Noriko Yanagitani, Ken Uchibori, Sumie Koike et al. · Cancer Science · 2020 · 48 citations · Full text

Medicine, Oncology, Pharmacology +15

Soluble PD-L1 works as a decoy in lung cancer immunotherapy via alternative polyadenylation

Ray Sagawa, Seiji Sakata, Bo Gong et al. · JCI Insight · 2021 · 48 citations · Full text

Life Sciences, Immunology, Oncology +17

Improvement in the survival of patients with stage IV non-small-cell lung cancer: Experience in a single institutional 1995–2017

Natsuki Takano, Ryo Ariyasu, Junji Koyama et al. · Lung Cancer · 2019 · 43 citations

Medicine, Oncology, Surgery +11

1–5 of 27